Cart
sales@molnova.com
PF-17
CAS No. 2697145-21-2
PF-17( —— )
Catalog No. M36412 CAS No. 2697145-21-2
PF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 227 | In Stock |
|
| 10MG | 307 | In Stock |
|
| 25MG | 473 | In Stock |
|
| 50MG | 617 | In Stock |
|
| 100MG | 840 | In Stock |
|
| 200MG | 1125 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-17
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
-
DescriptionPF-17 can be used as a PUF60 inhibitor for the treatment of ovarian cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2697145-21-2
-
Formula Weight448.54
-
Molecular FormulaC21H28N4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=CC(N2CCC(NC(OC(C)(C)C)=O)CC2)=NC=N1)C3=CC=C(S(C)(=O)=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LX-6171
LX-6171, a proline transporter (SLC6A7) inhibitor, is used potentially for the treatment of schizophrenia and Alzheimer's disease.
-
Combretastatin A-1
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.
-
CQ211
CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM, demonstrating significant proliferation inhibitory activity against various cancer cell lines in vitro.
